-
Zogenix, Inc. (NASDAQ: ZGNX) shares jumped 120.4
percent to $28.38 after the company announced top-line results from a phase 3 clinical trial exploring its drug called ZX008
for the treatment of Dravet syndrome. Zogenix said that its trial met its primary objective of demonstrating that ZX008, when
given to patients at a dose of 0.8 mg/kg/day, is superior to a placebo as adjunctive therapy in the treatment of Dravet
syndrome in children and young adults based on change in the frequency of convulsive seizures between the six-week baseline
observation period and the 14-week treatment period.
-
Acer Therapeutics Inc (NASDAQ: ACER) shares
climbed 31 percent to $18.74.
-
Veritone Inc (NASDAQ: VERI) shares surged 25.4
percent to $46.25. Roth Capital raised price target on Veritone from $13.00 to $62.00.
-
NuCana plc (NASDAQ: NCNA) shares rose 20 percent
to $19.36. NuCana priced its IPO of 6,667,000 American Depositary Shares at $15.00 per ADS.
-
Capricor Therapeutics Inc (NASDAQ: CAPR) shares
gained 17.5 percent to $2.59.
-
Roku Inc (NASDAQ: ROKU) shares jumped 17.5
percent to $27.60.
-
Comtech Telecomm. Corp. (NASDAQ: CMTL) shares
rose 17 percent to $20.60.
-
Helios and Matheson Analytics Inc (NASDAQ: HMNY)
shares surged 16.3 percent to $12.64.
-
Aradigm Corporation (NASDAQ: ARDM) shares gained
15 percent to $4.46.
-
A10 Networks Inc (NYSE: ATEN) shares climbed 14.4
percent to $7.61 as the company raised its guidance for the third quarter.
-
PTC Therapeutics, Inc. (NASDAQ: PTCT) rose 12.8
percent to $ 19.69 after an advisory panel to the FDA concluded on Thursday that the company's experimental drug to treat
Duchenne muscular dystrophy may work.
-
Smart Global Holdings Inc (NASDAQ: SGH) gained
11.6 percent to $25.12 after the company reported results for its fourth quarter.
-
Conn's Inc (NASDAQ: CONN) rose 9.2 percent to
$28.00. Oppenheimer upgraded Conn's from Perform to Outperform.
-
KB Home (NYSE: KBH) shares climbed 8.4 percent to
$24.10 as the company reported stronger-than-expected earnings for its third quarter on Thursday.
-
Aehr Test Systems (NASDAQ: AEHR) rose 8 percent
to $3.80. Aehr Test posted adjusted earnings of 0.01 per share in the first quarter, versus a year-ago adjusted loss of $0.03
per share. The company also disclosed that it has received follow-on orders for $2.7 million.
-
Tyson Foods, Inc. (NYSE: TSN) shares gained 7.6
percent to $70.43 as the company raised its outlook for fiscal 2017 and announced plans to cut around 450 jobs.
-
Heartland Express, Inc. (NASDAQ: HTLD) surged 7.3
percent to $25.00. Stifel Nicolaus upgraded Heartland Express from Hold to Buy.
-
ABIOMED, Inc. (NASDAQ: ABMD) rose 3.8 percent to
$168.40. SunTrust Robinson Humphrey initiated coverage on ABIOMED with a Buy rating.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.